C12Y 402/01011
Phosphopyruvate hydratase , i.e. enolase
Official title: Phosphopyruvate hydratase (4.2.1.11), i.e. enolase
C12Y402/01011 (Phosphopyruvate hydratase , i.e. enolase) appears on 35 US grants and 67 published applications in this corpus.
Search patents in C12Y- Granted patents
- 35
- Published applications
- 67
- Assignees
- 42
- Inventors
- 143
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 3 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 2 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 1 | 2 |
| 2013 | 0 | 0 |
| 2014 | 2 | 4 |
| 2015 | 0 | 4 |
| 2016 | 2 | 3 |
| 2017 | 2 | 6 |
| 2018 | 2 | 5 |
| 2019 | 5 | 5 |
| 2020 | 4 | 5 |
| 2021 | 0 | 4 |
| 2022 | 3 | 3 |
| 2023 | 2 | 6 |
| 2024 | 3 | 5 |
| 2025 | 4 | 4 |
| 2026 | 1 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and uses thereof27 Jan 2026US 12,533,392 B2SkinBio Therapeutics PLC
- Epitopes4 Nov 2025US 12,458,688 B2Scancell Limited
- Biomarker levels and neuroimaging for detecting, monitoring and treating brain injury or trauma4 Nov 2025US 12,461,112 B2Brainbox Solutions, Inc.
- Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems9 Sep 2025US 12,410,442 B2Decibel Therapeutics, Inc.
- Recombinant host cells and methods for the production of glyceric acid and downstream products7 Jan 2025US 12,188,008 B2Lygos, Inc.
- Biomarker levels and neuroimaging for detecting, monitoring and treating brain injury or trauma30 Jul 2026US 2026/0219284 A1Brainbox Solutions, Inc.
- Compositions and uses thereof16 Jul 2026US 2026/0199428 A1Skinbiotherapeutics PLC
- Compositions and methods comprising plants with modified seed composition30 Apr 2026US 2026/0117241 A1Confluence Genetics, LLC
- Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems5 Feb 2026US 2026/0035716 A1Decibel Therapeutics, Inc.
- Recombinant host cells and methods for the production of glyceric acid and downstream products30 Oct 2025US 2025/0333686 A1Lygos, Inc.
Most cited
By later US patents
- Neural transplantation using proliferated multipotent neural stem cells and their progeny176US 6,497,872 B1Neurospheres Holdings Ltd. · 2002
- Methods of screening biological agents23US 7,101,709 B2Neurospheres Holdings Ltd. · 2006
- Methods of proliferating undifferentiated neural cells17US 7,115,418 B2Neurospheres Holdings Ltd. · 2006
- Cell-free system for converting methane into fuel and chemical compounds13US 9,611,487 B2GreenLight Biosciences, Inc. · 2017
- Recombinant microorganisms capable of carbon fixation3US 10,294,482 B2Yeda Research and Development Co. Ltd. · 2019